Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced the results from its annual meeting of shareholders. A total of 42,008,160 common shares, or 67.85% of Nordion's issued and outstanding common shares, were voted in connection with the annual meeting. Shareholders voted in favour of all items of business, including election of each director nominee by a substantial majority as follows:
|William D. Anderson||93.49%|
|William G. Dempsey||90.95%|
|Mary A. Mogford||92.02%|
|Kenneth E. Newport||92.50%|
|Dr. Adeoye Olukotun||93.55%|
|Steven M. West||92.81%|
Following the annual meeting of shareholders, the board of directors of Nordion selected William D. Anderson to serve as Chair of the Company.
Mr. Robert W. Luba, an independent director who has served as a director of the Company since 1996, has reached retirement age and accordingly did not stand for re-election as a director at the annual meeting of shareholders. We thank Mr. Luba for his 16 years of wise counsel and dedicated service.